VolitionRx Limited Additional Paid in Capital, Common Stock
VolitionRx Limited (VNRX) had Additional Paid in Capital, Common Stock of $65.15 million as of 2017-09-30, per its 10-Q filed 2017-11-09.
Discontinued › Balance Sheet › Equity › Equity, Attributable to Parent
us-gaap:AdditionalPaidInCapitalCommonStock · last filed 2017-11-09
- 2017-09-30: Additional Paid in Capital, Common Stock $65.15M.
- 2017-06-30: Additional Paid in Capital, Common Stock $64.42M.
- 2017-03-31: Additional Paid in Capital, Common Stock $62.92M.
- 2016-12-31: Additional Paid in Capital, Common Stock $62.29M.
| Period end | Additional Paid in Capital, Common Stock |
|---|---|
| 2017-09-30 | $65.15M 10-Q · filed 2017-11-09 |
| 2017-06-30 | $64.42M 10-Q · filed 2017-08-10 |
| 2017-03-31 | $62.92M 10-Q · filed 2017-05-11 |
| 2016-12-31 | $62.29M 10-Q · filed 2017-11-09 |
| 2016-09-30 | $49.86M 10-Q · filed 2016-11-10 |
| 2015-12-31 | $35.15M 10-K · filed 2017-03-10 |
Similar stocks
| Stock Name | Country | Market Cap | PE Ratio |
|---|---|---|---|
| Cardio Diagnostics Holdings, Inc. (CDIO) | United States | $0.006B | |
| Q/C TECHNOLOGIES, INC. (QCLS) | United States | $0.008B | -1.93 |
| BIOMERICA INC (BMRA) | United States | $0.011B | |
| IMMUCELL CORP /DE/ (ICCC) | United States | $0.091B | 116.10 |
| Insight Molecular Diagnostics Inc. (IMDX) | United States | $0.129B | -3.90 |
| MYRIAD GENETICS INC (MYGN) | United States | $0.397B | -4.84 |
| Alpha Teknova, Inc. (TKNO) | United States | $0.500B | -18.12 |
| QuidelOrtho Corp (QDEL) | United States | $0.733B | -0.90 |
| ACHIEVE LIFE SCIENCES, INC. (ACHV) | United States | $0.806B | -5.88 |
| Intellia Therapeutics, Inc. (NTLA) | United States | $1.705B | -5.92 |